Somoskövi A - Search Results

1

Analysis of tuberculosis surveillance in Hungary in 2000.

Mester J, Vadász I, Pataki G, Parsons L, Fodor T, Salfinger M, Somoskövi A. Mester J, et al. Among authors: somoskovi a. Int J Tuberc Lung Dis. 2002 Nov;6(11):966-73. Int J Tuberc Lung Dis. 2002. PMID: 12475142

2

Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay.

Bártfai Z, Somoskövi A, Ködmön C, Szabó N, Puskás E, Kosztolányi L, Faragó E, Mester J, Parsons LM, Salfinger M. Bártfai Z, et al. Among authors: somoskovi a. J Clin Microbiol. 2001 Oct;39(10):3736-9. doi: 10.1128/JCM.39.10.3736-3739.2001. J Clin Microbiol. 2001. PMID: 11574605 Free PMC article.

3

Conventional and molecular epidemiology of tuberculosis in homeless patients in Budapest, Hungary.

Lukács J, Tubak V, Mester J, Dávid S, Bártfai Z, Kubica T, Niemann S, Somoskövi A. Lukács J, et al. Among authors: somoskovi a. J Clin Microbiol. 2004 Dec;42(12):5931-4. doi: 10.1128/JCM.42.12.5931-5934.2004. J Clin Microbiol. 2004. PMID: 15583345 Free PMC article.

4

The Race Is On To Shorten the Turnaround Time for Diagnosis of Multidrug-Resistant Tuberculosis.

Somoskovi A, Salfinger M. Somoskovi A, et al. J Clin Microbiol. 2015 Dec;53(12):3715-8. doi: 10.1128/JCM.02398-15. Epub 2015 Sep 16. J Clin Microbiol. 2015. PMID: 26378276 Free PMC article. Review.

5

The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis.

Somoskovi A, Parsons LM, Salfinger M. Somoskovi A, et al. Respir Res. 2001;2(3):164-8. doi: 10.1186/rr54. Epub 2001 Apr 5. Respir Res. 2001. PMID: 11686881 Free PMC article. Review.

6

Laboratory diagnostic aspects of drug resistant tuberculosis.

Parsons LM, Somoskövi A, Urbanczik R, Salfinger M. Parsons LM, et al. Among authors: somoskovi a. Front Biosci. 2004 Sep 1;9:2086-105. doi: 10.2741/1290. Front Biosci. 2004. PMID: 15353272 Review.

7

Line probe and automated real-time PCR TB assays warrant adherence to strict quality assurance measures.

Somoskovi A, Parsons LM, Gutierrez C, Lee E, Salfinger M. Somoskovi A, et al. Int J Tuberc Lung Dis. 2012 May;16(5):705-6. doi: 10.5588/ijtld.12.0078. Int J Tuberc Lung Dis. 2012. PMID: 22507939 No abstract available.

8

More on Treatment Outcomes in Multidrug-Resistant Tuberculosis.

Salfinger M, Somoskovi A. Salfinger M, et al. Among authors: somoskovi a. N Engl J Med. 2016 Dec 29;375(26):2609. doi: 10.1056/NEJMc1613123. N Engl J Med. 2016. PMID: 28032963 No abstract available.

9

Use of molecular methods to identify the Mycobacterium tuberculosis complex (MTBC) and other mycobacterial species and to detect rifampin resistance in MTBC isolates following growth detection with the BACTEC MGIT 960 system.

Somoskovi A, Song Q, Mester J, Tanner C, Hale YM, Parsons LM, Salfinger M. Somoskovi A, et al. J Clin Microbiol. 2003 Jul;41(7):2822-6. doi: 10.1128/JCM.41.7.2822-2826.2003. J Clin Microbiol. 2003. PMID: 12843007 Free PMC article.

10

Multidrug-resistant tuberculosis and bedaquiline.

Salfinger M, Somoskövi A. Salfinger M, et al. Among authors: somoskovi a. N Engl J Med. 2014 Dec 18;371(25):2435-6. doi: 10.1056/NEJMc1412235. N Engl J Med. 2014. PMID: 25517715 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters